NCT03144167: Study of Prognostic Biomarkers of Survival at 6 Months for Patients Treated With Bevacizumab Glioblastomas in First Relapse After Failure of Radiochemotherapy

Sponsor: Centre Hospitalier Universitaire, Amiens. Phase: NA. Conditions: Glioblastoma, Radiotherapy, Chemotherapy